These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4147379)

  • 1. [Dynamics and treatment of the tendency to enchronization of schizophrenic psychoses].
    López-Ibor Aliño JM
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(2):377-88. PubMed ID: 4147379
    [No Abstract]   [Full Text] [Related]  

  • 2. A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.
    Villeneuve A; Pires A; Jus A; Lachance R; Drolet A
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):696-706. PubMed ID: 4404626
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences with depot-neuroleptics in an after-care unit. Organization of the therapy exemplified with pipotiazine palmitate].
    Salvesen C; Vaksdal K
    Tidsskr Nor Laegeforen; 1973 Aug; 93(24):1699-703. PubMed ID: 4149082
    [No Abstract]   [Full Text] [Related]  

  • 4. Pipotiazine palmitate (19.552 R.P.) in the long-term treatment of chronic psychoses. A controlled trial on in-patients.
    Robak OH
    Acta Psychiatr Scand Suppl; 1973; 241():83-94. PubMed ID: 4147515
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
    Salvesen C; Vaksdal K
    Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740
    [No Abstract]   [Full Text] [Related]  

  • 6. Monthly intermittent chemotherapy of chronic schizophrenic outpatients with pipothiazine palmitate.
    Laurent JS; Carle R; Dumais B; Domingue D
    Can Psychiatr Assoc J; 1974 Dec; 19(6):583-91. PubMed ID: 4155349
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
    Pellet J; Guyotat J; Marie-Cardine M; Dubor P; Favre-Tissot M; Caron F; Cottraux J
    J Med Lyon; 1972 Apr; 53(227):591-8. PubMed ID: 4404295
    [No Abstract]   [Full Text] [Related]  

  • 8. Pilot trials with long-acting pipotiazine injections.
    Hakola A
    Acta Psychiatr Scand Suppl; 1973; 241():31-42. PubMed ID: 4147509
    [No Abstract]   [Full Text] [Related]  

  • 9. Uncontrolled study with pipothiazine palmitate.
    Jain RC; Ananth JV; Klingner A; Ban TA; Lehmann HE
    Int J Clin Pharmacol; 1973 Feb; 7(1):32-6. PubMed ID: 4699381
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of schizophrenia with imiclopazine, pimozide, imagotan and trifluorperidol. Comparative study].
    Nurowska K; Welbel L
    Psychiatr Pol; 1973; 7(1):57-63. PubMed ID: 4146043
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of penfluridol--a neuroleptic with prolonged action (oral administration) in the treatment of schizophrenic psychoses].
    Majczak A; Wielosz M; Grzywa A; Kornacki L; Nagay J; Jasińska M
    Psychiatr Pol; 1978; 12(5-6):555-62. PubMed ID: 724849
    [No Abstract]   [Full Text] [Related]  

  • 12. [Parenteral form of pipothiazine in the treatment of endogenous psychoses].
    Matkowski K; Martenka E; Nobis T
    Psychiatr Pol; 1984; 18(6):567-70. PubMed ID: 6152666
    [No Abstract]   [Full Text] [Related]  

  • 13. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
    Buis C; Gourion D; Vaiva G
    Encephale; 2009 Jan; Suppl 3():S91-5. PubMed ID: 19268185
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experience with the neuroleptic 19.366 R.P. (pipothiazine)].
    Arrojo Lois M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(3):309-12. PubMed ID: 31067
    [No Abstract]   [Full Text] [Related]  

  • 15. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). What are the limiting factors in resort to an APAP and how to overcome them].
    Canceil O; Limosin F; Passerieux C
    Encephale; 2009 Jan; Suppl 3():S101-7. PubMed ID: 19268178
    [No Abstract]   [Full Text] [Related]  

  • 16. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 17. A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.
    Wei FC; Jann MW; Lin HN; Piao-Chien C; Chang WH
    J Clin Psychiatry; 1996 Jul; 57(7):298-302. PubMed ID: 8666571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients.
    Ban TA; Ananth JV; Lehmann HE
    Act Nerv Super (Praha); 1974 Mar; 16(1):23-33. PubMed ID: 4156144
    [No Abstract]   [Full Text] [Related]  

  • 19. A pilot study of pimozide in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):706-13. PubMed ID: 5000718
    [No Abstract]   [Full Text] [Related]  

  • 20. General evaluation of pipotiazine palmitate in hospitalized and open ward patients with functional psychosis.
    Salvesen C; Vaksdal K
    Acta Psychiatr Scand Suppl; 1973; 241():57-67. PubMed ID: 4147512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.